?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika · USA
Filter & Suche
173 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
173 Unternehmen gefunden • Seite 2 von 7
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Krystal Biotech Inc | 66.6 | Arzneimittel (Biotechnologie) | USA | 9.5 Mrd. USD | 39.40 | 36.91 | 21.60 | 7.00 | - | - | - | - | - | 52.64% | - | 41.45% | - | 48.55% | - | 6 / 9 | 16,76 | unbegrenzt | 27 / 100 | 0,3 / 100 | −2,26 |
 | AbbVie Inc | 65.9 | Arzneimittel (Biotechnologie) | USA | 505.4 Mrd. USD | 80.04 | 27.75 | 7.85 | -85.15 | ▲ 5.95% | ▼ -1.75% | 2.42% | ▲ 5.88% | 12 Jahre | 6.91% | ▼ -4.01% | 32.85% | ▼ -1.31% | 29.13% | ▼ -3.01% | 8 / 9 | −0,62 | 3-fach | 32 / 100 | −11,1 / 100 | −2,94 |
 | Biomarin Pharmaceutical Inc | 65.9 | Arzneimittel (Biotechnologie) | USA | 10.8 Mrd. USD | 148.55 | 14.79 | 3.18 | 1.71 | ▲ 11.60% | ▼ -16.49% | - | - | - | 10.83% | ▲ 3.68% | 16.56% | ▲ 5.13% | 22.51% | ▲ 3.90% | 6 / 9 | 7,50 | 31-fach | 33 / 100 | −6,3 / 100 | −2,67 |
 | Rhythm Pharmaceuticals Inc | 65.9 | Arzneimittel (Biotechnologie) | USA | 6.4 Mrd. USD | - | - | 26.86 | 29.65 | ▲ 458.25% | ▲ 8.50% | - | - | - | -103.57% | ▲ 467.12% | -101.19% | ▲ 1113.52% | -61.46% | ▲ 1014.42% | 6 / 9 | −5,35 | −10,6-fach | 35 / 100 | −16,8 / 100 | −2,97 |
 | PTC Therapeutics Inc | 65.5 | Arzneimittel (Biotechnologie) | USA | 5.3 Mrd. USD | - | - | 5.21 | -31.81 | ▲ 35.37% | - | - | - | - | 39.44% | ▲ 30.84% | 49.49% | ▲ 26.45% | 23.76% | ▲ 22.28% | 7 / 9 | 1,52 | 0-fach | 57 / 100 | −1,0 / 100 | −1,66 |
 | BioCryst Pharmaceuticals Inc | 64.5 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | - | 5.99 | 2.27 | -4.71 | ▲ 117.89% | - | - | - | - | 30.16% | ▲ 36.61% | 38.98% | ▲ 35.83% | 37.43% | ▲ 30.73% | 7 / 9 | −2,56 | 1-fach | 166 / 100 | −12,8 / 100 | −2,23 |
 | Vericel Corp Ord | 63.5 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | 86.87 | 42.39 | 6.87 | 5.69 | ▲ 17.34% | ▲ 41.97% | - | - | - | 5.98% | ▲ 3.61% | 4.00% | ▲ 3.03% | 8.96% | ▼ -1.77% | 7 / 9 | 3,21 | 10-fach | 42 / 100 | −7,2 / 100 | −2,42 |
 | Abbott Laboratories | 63.4 | Arzneimittel (Pharmazeutisch) | USA | 177.6 Mrd. USD | 37.78 | 22.42 | 3.68 | - | ▲ 5.08% | ▲ 7.74% | 2.44% | ▲ 6.96% | 12 Jahre | 14.72% | ▲ 1.27% | 18.16% | ▼ -0.93% | 16.68% | ▼ -0.95% | 6 / 9 | 4,91 | 14-fach | 29 / 100 | −3,5 / 100 | −2,54 |
 | Indivior PLC Ordinary Shares | 62.5 | Arzneimittel (Biotechnologie) | USA | 4.2 Mrd. USD | 11.72 | - | 3.12 | -20.00 | ▲ 13.88% | - | - | - | - | 16.95% | ▼ -1.29% | 21.39% | ▲ 0.06% | -7.59% | ▼ -9.44% | 5 / 9 | −0,58 | 2-fach | 82 / 100 | 19,7 / 100 | −1,38 |
 | CorMedix Inc | 62.5 | Arzneimittel (Pharmazeutisch) | USA | 0.6 Mrd. USD | 3.41 | 2.55 | 1.38 | 1.39 | ▲ 305.80% | - | - | - | - | 52.31% | ▲ 3325.35% | 48.17% | ▲ 3821.93% | 55.43% | ▲ 3027.98% | 6 / 9 | 3,09 | 36-fach | 33 / 100 | −1,5 / 100 | 6,23 |
 | Puma Biotechnology Inc | 62.3 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | 20.36 | 13.24 | 2.35 | 3.93 | ▲ 0.29% | - | - | - | - | 13.62% | ▲ 6.34% | 16.33% | ▲ 3.47% | 18.27% | ▲ 4.71% | 8 / 9 | −13,97 | 4-fach | 79 / 100 | −4,9 / 100 | −2,11 |
 | Innoviva Inc | 60.5 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 4.27 | 8.10 | 3.44 | 1.24 | ▲ 4.77% | ▲ 3.86% | - | - | - | 63.78% | ▼ -6.62% | 38.52% | ▼ -13.04% | 43.85% | ▼ -10.56% | 6 / 9 | 7,33 | 11-fach | 19 / 100 | 4,5 / 100 | −2,26 |
 | MannKind Corp | 60.2 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 2.80 | -16.41 | ▲ 39.89% | - | - | - | - | 1.68% | ▲ 31.52% | 11.12% | ▲ 23.66% | 3.92% | ▲ 30.18% | 6 / 9 | −11,95 | 1-fach | 36 / 100 | −1,6 / 100 | 0,71 |
 | Royalty Pharma Plc | 60.1 | Arzneimittel (Pharmazeutisch) | USA | 37.5 Mrd. USD | 45.94 | 12.59 | 14.77 | 5.48 | ▲ 2.30% | ▼ -4.59% | 1.45% | ▲ 6.69% | 5 Jahre | 32.42% | ▲ 4.67% | 65.58% | ▲ 4.95% | 104.69% | ▲ 15.09% | 5 / 9 | 1,82 | 7-fach | 15 / 100 | −10,5 / 100 | 5,50 |
 | Bristol-Myers Squibb Company | 58.7 | Arzneimittel (Pharmazeutisch) | USA | 125.4 Mrd. USD | 13.51 | 10.96 | 2.55 | 5.62 | ▲ 2.54% | - | 4.16% | - | 4 Jahre | 14.64% | ▼ -3.31% | 28.48% | ▲ 1.26% | 26.65% | ▼ -0.94% | 8 / 9 | 2,16 | 3-fach | 38 / 100 | −7,9 / 100 | −2,73 |
 | Xeris Pharmaceuticals Inc | 58.5 | Arzneimittel (Pharmazeutisch) | USA | 2.0 Mrd. USD | - | 35.39 | 5.84 | -201.35 | ▲ 154.71% | - | - | - | - | 0.19% | ▲ 55.42% | 8.53% | ▲ 53.92% | 9.57% | ▲ 48.40% | 7 / 9 | −2,91 | −0,4-fach | 62 / 100 | −7,3 / 100 | −2,57 |
 | Ligand Pharmaceuticals Incorporated | 58.5 | Arzneimittel (Pharmazeutisch) | USA | 6.4 Mrd. USD | 32.22 | 48.38 | 21.87 | 6.57 | ▲ 10.39% | - | - | - | - | 46.42% | ▲ 5.98% | 17.61% | ▼ -6.59% | 18.24% | ▼ -3.63% | 7 / 9 | 7,28 | 28-fach | 17 / 100 | 4,8 / 100 | −1,79 |
 | Amphastar P | 57.5 | Arzneimittel (Pharmazeutisch) | USA | 1.1 Mrd. USD | 14.26 | 7.33 | 1.53 | 1.46 | ▲ 15.53% | ▲ 133.84% | - | - | - | 13.63% | ▲ 0.24% | 19.50% | ▲ 1.36% | 16.84% | ▲ 1.19% | 6 / 9 | 4,86 | 7-fach | 22 / 100 | −3,6 / 100 | −2,70 |
 | Alnylam Pharmaceuticals Inc | 56.5 | Arzneimittel (Biotechnologie) | USA | 31.1 Mrd. USD | 38.49 | 57.32 | 6.47 | 22.96 | ▲ 49.77% | - | - | - | - | 8.45% | ▲ 31.56% | 13.51% | ▲ 26.27% | 12.53% | ▲ 25.24% | 6 / 9 | −0,01 | 0-fach | 61 / 100 | −4,2 / 100 | −2,01 |
| Collegium Pharmaceutical Inc | 54.6 | Arzneimittel (Pharmazeutisch) | USA | 0.8 Mrd. USD | 15.78 | 2.30 | 0.94 | 2.42 | ▲ 20.28% | ▲ 18.64% | - | - | - | 8.05% | ▼ -1.92% | 23.97% | ▲ 5.49% | 41.97% | ▲ 1.63% | 6 / 9 | 1,74 | 2-fach | 28 / 100 | −16,1 / 100 | −3,34 |
 | Corcept Therapeutics Incorporated | 53.0 | Arzneimittel (Pharmazeutisch) | USA | 9.3 Mrd. USD | 169.90 | 87.23 | 11.23 | 13.21 | ▲ 16.56% | ▼ -1.23% | - | - | - | 13.09% | ▼ -3.98% | 5.88% | ▼ -6.40% | 18.62% | ▼ -5.51% | 4 / 9 | 9,15 | unbegrenzt | 89 / 100 | −5,1 / 100 | −2,87 |
 | Pfizer Inc | 52.9 | Arzneimittel (Pharmazeutisch) | USA | 167.9 Mrd. USD | 38.75 | 15.28 | 2.64 | 1.97 | ▲ 8.48% | ▼ -4.17% | 5.84% | ▲ 1.97% | 15 Jahre | 12.42% | ▼ -4.76% | 27.82% | ▼ -0.84% | 14.50% | ▼ -5.48% | 7 / 9 | 3,06 | 3-fach | 22 / 100 | −1,9 / 100 | −2,53 |
 | Eton Pharmaceuticals Inc | 51.5 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 120.91 | 104.20 | 14.53 | 32.93 | ▲ 359.57% | ▼ -30.30% | - | - | - | -5.75% | ▲ 3.90% | 0.09% | ▲ 4.61% | 12.75% | ▲ 9.14% | 4 / 9 | −1,98 | −0,2-fach | 46 / 100 | −16,4 / 100 | −2,45 |
 | ANI Pharmaceuticals Inc | 50.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | 15.57 | 12.04 | 1.68 | 2.76 | ▲ 33.48% | - | - | - | - | 8.87% | ▲ 6.93% | 9.20% | ▲ 6.65% | 17.08% | ▲ 7.57% | 6 / 9 | 3,28 | 2-fach | 31 / 100 | −7,4 / 100 | −2,62 |
 | Lineage Cell Therapeutics Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 20.10 | 4.32 | ▲ 79.88% | ▲ 25.20% | - | - | - | -436.47% | ▲ 131.82% | -149.62% | ▲ 215.40% | -133.56% | ▲ 70.71% | 4 / 9 | −14,00 | - | 12 / 100 | −39,2 / 100 | −3,22 |
USA